Favreau, M., Venken, K., Faict, S., Maes, K., De Veirman, K., De Bruyne, E., . . . Menu, E. (2017). Both mucosal-associated invariant and natural killer T-cell deficiency in multiple myeloma can be countered by PD-1 inhibition. Haematologica.
Παραπομπή Chicago StyleFavreau, Mérédis, et al. "Both Mucosal-associated Invariant and Natural Killer T-cell Deficiency in Multiple Myeloma Can Be Countered By PD-1 Inhibition." Haematologica 2017.
Παραπομπή MLAFavreau, Mérédis, et al. "Both Mucosal-associated Invariant and Natural Killer T-cell Deficiency in Multiple Myeloma Can Be Countered By PD-1 Inhibition." Haematologica 2017.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.